Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FINERENONE, with a corresponding US DMF Number 41150.
Remarkably, this DMF maintains an Active status since its submission on January 10, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 28, 2025, and payment made on January 22, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II